←
QV Bioelectronics245 posts
QV Bioelectronics avatar

QV Bioelectronics

@qvbio

Preclinical medical device startup based in Cheshire, UK. Developing a ground-breaking electric field therapy implant to treat aggressive brain tumours.

◷ Joined September 2019▧ 104 Photos and videos
QV Bioelectronics avatar
QV Bioelectronics@qvbio·Jan 21

We’ve secured £4.5m in investment and grant funding to advance GRACE, our fully implantable electric field therapy for glioblastoma, into clinical studies. Thank you to our investors, funders, and partners for the support. Fully story here: lnkd.in/dgYS8fge

Post attachment
QV Bioelectronics avatar
QV Bioelectronics@qvbio·Mar 17

QV Bioelectronics announces a leadership update 🚀 Carl Daintree is now CEO, bringing strong experience in medtech 🧬 Co-founder Chris Bullock becomes CTO, focusing on advancing our bioelectronic platform for brain tumours Read in full 👇 qvbio.co.uk/leadership-updat…

Post attachment
QV Bioelectronics avatar
QV Bioelectronics@qvbio·6 May 2025

⏳ We’ve got some exciting news to share tomorrow at QV Bioelectronics. Looking forward to sharing more very soon.

Post attachment
QV Bioelectronics avatar
QV Bioelectronics@qvbio·12 Mar 2025

Excited to welcome Carl Daintree as QV's new COO! 🚀 Carl brings expertise across medtech, pharma & biotech. At 30 Technology, he led products from prototype to exit, driving clinical studies & market strategy. Thrilled to have him as we advance brain tumour treatment! 🧠

Post attachment
Brain Innovation Days avatar
⟳ QV Bioelectronics retweeted
Brain Innovation Days@BrainDays·14 Nov 2024

After a rigorous selection process, 5 innovative start-ups are pitching their ground-breaking solutions in the brain health space! 🧠💡  🎤 @qvbio , BrainTale, CREATe Therapeutics, Paperbox and @Rebrain_eu take the stage for this pitch competition in front of five jury members!

Post attachmentPost attachmentPost attachment
QV Bioelectronics avatar
QV Bioelectronics@qvbio·9 Sep 2024

🚀 Big News from QV Bioelectronics! 🚀 We’re excited to announce breakthrough pre-clinical results for our Glioblastoma therapy! 💼Now Raising Series A More details in our press release below🔗 rb.gy/z446y3

Post attachment
GM&C Life Sciences avatar
⟳ QV Bioelectronics retweeted
GM&C Life Sciences@gmclifesciences·5 Sep 2024

@qvbio secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours

🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️ This supports early-stage development & testing, advancing new options and expanding our portfolio.

Post attachment
QV Bioelectronics avatar
QV Bioelectronics@qvbio·29 Aug 2024

🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️ This supports early-stage development & testing, advancing new options and expanding our portfolio.

Post attachment
GM&C Life Sciences avatar
⟳ QV Bioelectronics retweeted
GM&C Life Sciences@gmclifesciences·24 Oct 2023

@qvbio and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma qvbio.co.uk/qv-bioelectronic…